A perspective on the contribution of metabolites to drug-drug interaction potential: the need to consider both circulating levels and inhibition potency.
第一作者:
Hongbin,Yu
第一单位:
Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877, USA. hongbin.yu@boehringer-ingelheim.com
作者:
医学主题词
动物(Animals);曲线下面积(Area Under Curve);生物转化(Biotransformation);细胞色素P450酶系统(Cytochrome P-450 Enzyme System);决策树(Decision Trees);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物相互作用(Drug Interactions);酶抑制剂(Enzyme Inhibitors);人类(Humans);模型, 生物学(Models, Biological);模型, 统计学(Models, Statistical);分子结构(Molecular Structure);药用制剂(Pharmaceutical Preparations);危险性评估(Risk Assessment);构效关系(Structure-Activity Relationship)
DOI
10.1124/dmd.112.048892
PMID
23143892
发布时间
2025-02-12
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



